LifePlan Financial Group’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$3K Hold
35
﹤0.01% 515
2020
Q2
$3K Hold
35
﹤0.01% 518
2020
Q1
$3K Hold
35
﹤0.01% 495
2019
Q4
$3K Hold
35
﹤0.01% 501
2019
Q3
$3K Hold
35
﹤0.01% 497
2019
Q2
$3K Sell
35
-4
-10% -$339 ﹤0.01% 495
2019
Q1
$3K Hold
39
﹤0.01% 496
2018
Q4
$3K Hold
39
﹤0.01% 480
2018
Q3
$3K Buy
+39
New +$2.88K ﹤0.01% 484
2018
Q2
Sell
-15
Closed -$1K 541
2018
Q1
$1K Buy
+15
New +$1.14K ﹤0.01% 497
2014
Q2
Sell
-683
Closed -$52K 162
2014
Q1
$52K Buy
+683
New +$49.8K 0.04% 117

Other funds holding NVS

LifePlan Financial Group's NVS Position: Q3 2020 in Review

LifePlan Financial Group held its Novartis (NVS) position steady in Q3 2020 at 35 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #515.

LifePlan Financial Group first reported a position in NVS in Q1 2014 and has held it in 11 quarters since. The position peaked at $52K in Q1 2014. 1,118 funds tracked by Wall St. Rank hold NVS as of Q3 2020.

  • LifePlan Financial Group held 35 shares of Novartis worth $3K as of Q3 2020.
  • LifePlan Financial Group left its Novartis share count unchanged in Q3 2020.
  • Novartis made up ﹤0.01% of LifePlan Financial Group's portfolio in Q3 2020, its #515 holding.
  • LifePlan Financial Group first reported a position in Novartis in Q1 2014 and has held it in 11 quarters since.
  • LifePlan Financial Group's Novartis position peaked at $52K in Q1 2014.
  • 1,118 funds tracked by Wall St. Rank held Novartis as of Q3 2020.

Based on LifePlan Financial Group's 13F filing for Q3 2020, filed 30 Oct 2020.